Supporting previous observations, the lack of significant tau pathology in our first case suggests that contrary to Alzheimer ́s disease, tau pathology may not be the driving pathophysiological mechanism of cognitive impairment in iCAA [9]. The gene discussed is MAPT; the disease is Cognitive impairment.